The article detailing the use of placenta-tropic VEGF mRNA lipid nanoparticles to ameliorate murine pre-eclampsia has undergone corrections to improve accuracy. Key amendments include adjustments to figure labels and citations, impacting the interpretation of results related to lipid nanoparticle delivery mechanisms. The corrected details on experimental figures emphasize the importance of accurate data representation in genetic and therapeutic research, ensuring the scientific integrity of findings in the context of placental health and related conditions like pre-eclampsia.
In the version of the article initially published, in Fig. 2b, the x-axis label has now been amended to accurately reflect the intended data representation.
These corrections have been made to the HTML and PDF versions of the article to clarify the results regarding lipid nanoparticle delivery mechanisms.
Collection
[
|
...
]